[Advances in the Study of Expression and Regulation of P-glycoprotein].

Cheng-Jun Shi,Li-Wu Fu
DOI: https://doi.org/10.3321/j.issn:0513-4870.2007.09.001
2007-01-01
Abstract:Resistance to the cytotoxic actions of antineoplastic drugs remains a barrier to the establishment of curative chemotherapy regimens for cancer. Over-expression of P-glycoprotein (P-gp), encoded by the MDR1 gene is the major molecular mechanism enhancing efflux pump for various anticancer agents, hence caused MDR. Transcription factor, DNA methylation, histone acetylation/deacetylation, phosphorylation and glycosylation and MDR1 gene polymorphisms play pivotal role in regulation of P-glycoprotein, and may become new therapeutic targets. This paper summarized the advances of studies on expression and regulation of P-glycoprotein.
What problem does this paper attempt to address?